Abstract
The efficacy of 10-μg and 40-μg hepatitis B vaccines was compared with that of an investigational vaccine containing pre-S1, pre-S2, and S subunit particles (mixed particle vaccine) in inducing protective anti-hepatitis B surface antigen (anti-HBs) concentrations in 46 otherwise healthy persons who previously did not develop measurable levels of antibodies to at least one complete course of vaccine. A statistically significant difference was seen in the percentage of subjects who developed protective levels of anti-HBs (≤10 mIU/mL) with three 40-μg doses of S subunit vaccine versus the other groups. One hundred percent of the 40-μg dose group developed protective anti-HBs titers. No difference in adverse effects was noted.
Original language | English (US) |
---|---|
Pages (from-to) | 678-681 |
Number of pages | 4 |
Journal | Journal of Infectious Diseases |
Volume | 175 |
Issue number | 3 |
DOIs | |
State | Published - 1997 |
ASJC Scopus subject areas
- Immunology and Allergy
- Infectious Diseases